Description

BSE announces listing of Commercial Papers worth Rs. 350 crores issued by Infina Finance Private Limited maturing in March 2026 and December 2026.

Summary

BSE has listed two series of Commercial Papers issued by Infina Finance Private Limited on private placement basis, effective December 16, 2025. The instruments comprise 2,000 units of Rs. 5 lakh each maturing in March 2026 (total Rs. 100 crores) and 5,000 units of Rs. 5 lakh each maturing in December 2026 (total Rs. 250 crores). Both series carry CRISIL A1+ and ICRA A1+ ratings, with Kotak Mahindra Bank Limited acting as the Issuing and Paying Agent.

Key Points

  • Two Commercial Paper series listed on BSE Debt segment
  • First series: 2,000 units (Rs. 100 crores) maturing March 16, 2026 - ISIN: INE879F14MD0, Scrip Code: 730776
  • Second series: 5,000 units (Rs. 250 crores) maturing December 14, 2026 - ISIN: INE879F14ME8, Scrip Code: 730777
  • Face value and paid-up value: Rs. 5,00,000 per unit for both series
  • Issue prices: Rs. 4,91,652.50 (first series) and Rs. 4,65,421.00 (second series)
  • Credit ratings: CRISIL A1+ and ICRA A1+ for both series
  • Allotment date: December 15, 2025
  • Trading only in dematerialized form
  • Standard denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise
  • Market lot: 1 unit

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under the specified ISIN numbers
  • Trading must be conducted in standard denomination of Rs. 5 lakhs and multiples thereof
  • Members should use the tick size of 1 paise for these securities

Important Dates

  • Allotment Date: December 15, 2025
  • Listing Date: December 16, 2025
  • Redemption Date (First Series): March 16, 2026
  • Redemption Date (Second Series): December 14, 2026

Impact Assessment

This listing has minimal market impact as it involves private placement of commercial paper in the debt segment. The instruments are rated A1+ by both CRISIL and ICRA, indicating highest safety regarding timely payment. The listing provides short-term to medium-term debt instruments for institutional investors seeking highly rated commercial paper. No impact on equity markets or retail investors.

Impact Justification

Routine listing of commercial paper on private placement basis with no impact on equity markets or broad market participants